The CD8 molecule regulates T cell activation mediated via the CD3 T ce
ll receptor and the adhesion molecule CD2. CD8 mAbs have been found to
inhibit early (Ca2+ rise) as well as late events (cytotoxicity, proli
feration, and lymphokine secretion) mediated via the CD2 pathway. A pa
nel of eight anti-human CD8 mAbs was tested for inhibition of CD2-medi
ated Ca2+ rise in a cytotoxic T cell clone. The inhibition ranged from
5 to 53% independently of mAb isotype and affinity measured by half s
aturation binding. We then characterized these mAbs for their reactivi
ty toward three mutants of the human CD8 alpha carrying amino acid seq
uence changes in the surface exposed loops homologous to the immunoglo
bulin CDR1, 2, and 3. The mutations included replacement of the human
CD8 alpha CDR1- and CDR2-like loops by the homologous mouse sequences
and the insertion of a glycine in the middle of the CDR3-like loop. Th
us, five mAbs were found to be affected by the mutation in the CDR2-li
ke loop but not by alterations in the other CDR-like loops. Conversely
, the other two mAbs (8E1.7 and B9.8) were affected only by mutations
in the CDR1- and CDR3-like loops, respectively. Cross-inhibition exper
iments were essentially in agreement with these results. interestingly
, all the mAbs directed against the CDR2-like loop were potent inhibit
ors of CD2-mediated Ca2+ rise, with one exception probably due to poor
affinity. Thus, in addition to being a site of interaction with major
histocompatibility complex Class I as recent data have indicated, thi
s region of the CD8 alpha subunit may play a role in regulating T cell
activation. (C) 1994 Academic Press, Inc.